Monday, December 07, 2009
Fate of Compliant license uncertain
We reported on Compliant Therapeutics hopes for a license for Vanderbilt nanotechnology, but by midday that had clearly been threatened. Entrepreneur Eric Elmquist has other plans, but none perhaps so immediately compelling as this starter idea. There may've been a miscue, somewhere along the road. Read about it here.